|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
KalVista Pharmaceuticals Inc.
| | | Phone: | (857) 999-0075 | Fax: | (857) 241-3601 | Year Established: | 2005 | Ticker: | KALV | Exchange: | NASDAQ | Main Contact: | T. Andrew Crockett, MBA, CEO | | Other Contacts: | Christopher M. Yea, PhD, Chief Development Officer Edward P. Feener, PhD, CSO Andreas Maetzel, MD, PhD, Senior VP, Medical Benjamin L. Palleiko, MBA, CFO
| | Company Description | KalVista Pharmaceuticals is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body's inflammatory response, and which in excess can lead to increased vascular permeability, edema and inflammation. | |
|
|
|
|
|